$8 Million Grant to UdeM Researchers to Advance Parkinson’s Disease Understanding
$8 Million Grant Fuels U.S.-Canada Research Collaboration on Parkinson’s Disease
Montreal,Quebec – A groundbreaking research project aimed at unraveling the role of the immune system in Parkinson’s disease has received a major boost with an $8 million grant from Aligning Science Across Parkinson’s (ASAP). The funding will support a team of researchers from the University of Montreal and McGill University, led by Professor Michel Desjardins.
[Image: Michel Desjardins, Credit: amélie Philibert, Université de Montréal]
This significant investment, made possible through a partnership with the Michael J.Fox Foundation for Parkinson’s Research, will allow the team to build upon their previous work, which was initially funded by ASAP in 2020. The researchers will delve deeper into the complex interplay between the immune system, bacterial and viral infections, and the development of Parkinson’s disease.
“This highly competitive funding is a testament to the groundbreaking work being done by Professor Desjardins and his team,” said [Quote from a relevant university official, emphasizing the importance of the research and the collaboration].
Parkinson’s disease,a debilitating neurodegenerative disorder,affects millions worldwide. In the United States alone, over one million people live with the condition. This number is projected to rise significantly in the coming years due to an aging population.
The research team, comprised of experts from the University of Montreal’s Faculty of Medicine and mcgill University, will leverage their combined expertise in immunology, neurology, and pharmacology to gain a better understanding of the disease’s underlying mechanisms. Their findings could pave the way for the development of novel therapies and preventative strategies for Parkinson’s disease.
This collaborative effort between two leading Canadian universities highlights the importance of international research partnerships in tackling complex health challenges. The ASAP grant represents a significant step forward in the fight against parkinson’s disease, offering hope for improved treatments and ultimately, a cure.
Unmasking Parkinson’s: $8 Million Grant Fuels U.S.-Canada Research Collaboration
Montreal, Quebec – In a major breakthrough for Parkinson’s research, a team of canadian scientists has secured an $8 million grant from aligning Science Across Parkinson’s (ASAP) to investigate the intricate link between the immune system and this debilitating neurodegenerative disease.
Professor Michel Desjardins, leading the research at the University of Montreal and McGill university, expressed excitement about the opportunity to delve deeper into the complex interplay between the immune system, bacterial and viral infections, and parkinson’s advancement.”This highly competitive funding is a testament to the groundbreaking work being done by Professor desjardins and his team,” said [Quote from a relevant university official, emphasizing the importance of the research and the collaboration].
This important investment, made possible through a partnership with the Michael J.Fox Foundation for Parkinson’s Research, builds upon the team’s previous work initially funded by ASAP in 2020. Their research, involving experts from the University of Montreal’s Faculty of Medicine and McGill University, will leverage expertise in immunology, neurology, and pharmacology to unravel the mysteries surrounding Parkinson’s disease.
This collaborative effort between two leading Canadian universities underscores the power of international partnerships in tackling complex health challenges. With Parkinson’s affecting millions worldwide, including over one million people in the United States alone, the ASAP grant offers a beacon of hope for improved treatments and, ultimately, a cure for this devastating condition.